27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
It is no surprise to any Iowa employer that the state has one of the most complex drug testing statu...
Read More >
When crafting a liquidation or “pass-through” agreement for a subcontractor claim against the gove...
Read More >
At an increasing rate, employers who hire STEM OPT students are being audited by U.S. Immigration an...
Read More >
It’s been tough to keep up with developments concerning the fallout from the Dynamex case and Calif...
Read More >
Toledo, Ohio recently joined the growing number of nationwide jurisdictions to pass local ordinances...
Read More >
The labor movement sent a powerful and potentially revolutionary signal to the tech industry this pa...
Read More >